Health

Results: 529-540 of 9495

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat

The ZoyeMed 3.0 Resilience Edition - a fully standalone clinical AI terminal engineered to operate without internet connectivity, integrating point-of-care diagnostics, examination tools, and on-device AI in a single 5-square-metre footprint (Photo: AETOSWire)

Zoya Technologies Launches Clinical AI Terminal Engineered to Operate Without Internet Connectivity

PR Newswire associated0

Sysmex launches HISCL™ platform, enabling faster, scalable Alzheimer's blood testing

Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK

Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology

Ping An Good Doctor Upgrades AI Doctor Service "Ping An AI Doctor", Expanding Access to Ping An Ecosystem's 90 Million MAUs

Ping An Good Doctor Upgrades AI Doctor Service "Ping An AI Doctor", Expanding Access to Ping An Ecosystem's 90 Million MAUs

Figure 1. Random acoustic bombardment (prior art) vs. targeted resonance frequency matching.

Dr Mom Hand Unveils Phyto-Resonance®

KFSH Highlights Innovation Infrastructure as the Foundation for Sustainable Healthcare Transformation at HLTH Europe 2026

LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

Sai Life Sciences achieves EcoVadis Platinum Rating, joining the top 1% of companies assessed worldwide

Sai Life Sciences Achieves EcoVadis Platinum Rating, Joining the Top 1% of Companies Assessed Worldwide

2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy